Result Summary for 208141/004
| Protocol ID: | 208141/004 |
| Clinical Study ID: | 208141/004 |
| Official Title: | A feasibility study to evaluate the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' Herpes simplex candidate vaccine (gD2t), with Monophosphoryl Lipid A (MPL) and with or without Tween in initially HSV-seronegative subjects. |
| Phase: | phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | Herpes Simplex Vaccine |
| Trade/Product Name: | Herpes Simplex Vaccine |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
